Erfurt/Jena: Redwave Medical GmbH, based in Jena, Germany, develops and distributes a new type of algorithm for blood pressure measuring devices for fast, inexpensive and simple determination of the central blood pressure and for checking the overall arterial status. Due to its patented measurement technology, the Redwave algorithm is suitable for the first time for use in home blood pressure monitors and is expected to revolutionise individual health monitoring.
Recently, the four-member founding team was able to close the seed financing round and in this context was able to win the Thüringer Aufbaubank subsidiary bm|t (bm‑t beteiligungsmanagement thüringen gmbh) as lead investor and the experienced serial entrepreneur Dr. Gerhard Scheuch as co-investor.
Why central blood pressure?
For years, hypertension patients have been measuring their own blood pressure at home as part of their therapy. This is done with devices on the upper arm or wrist, which gives the blood pressure values in the arm. However, current studies show that central blood pressure (in the aorta) is much more suitable for guiding prognosis and therapy. This central blood pressure directly affects important organs such as the heart, kidneys or brain and is thus responsible for the risk of heart attack or stroke. Experts already recommend that high blood pressure therapy be geared to central blood pressure. However, there is currently no way for patients to reliably measure these values themselves at home. Redwave finally makes it possible to determine central blood pressure and other health-relevant values from the familiar cuff measurement on the arm.
How was Redwave able to convince the investors?
The founders are convincing with their extensive professional experience in the field of medical technology, especially pulse wave analysis. The technical, medical and commercial competences complement each other perfectly in the team and are based on many years of cooperation. In addition, a prototype of the algorithm is already available and the innovative content as well as the potential for success have already been confirmed in initial discussions with customers.
About Redwave Medical GmbH:
Redwave Medical GmbH was founded on 05 May 2017 and specialises in biosignal analysis and medical algorithms. Currently, the company is developing the first algorithm for blood pressure cuffs that enables the determination of central blood pressure (in the aorta) and the verification of the entire arterial status at home.
bm‑t beteiligungsmanagement thüringen gmbh, based in Erfurt, is a subsidiary of the Thüringer Aufbaubank and one of the first addresses for investments in Thuringia. bm|t currently manages eight funds with a total volume of around EUR 320 million, which invest in innovative companies in almost all sectors and in all phases of company development — both in the start-up and growth phases or in company succession situations. Currently, around EUR 100 million is available for early-stage projects, for growth companies and for established medium-sized and large companies in Thuringia’s SME sector.
Redwave Medical GmbH
Phone: +49 174 91 323 63
bm‑t beteiligungsmanagement thüringen gmbh
Phone: +49 361 7447–593